In this episode, Dr. C. Joe Northup, MD, FACS, FASMBS, Bariatric Surgeon & 40th President of the American Society for Metabolic and Bariatric Surgery (ASMBS), discusses the impact of GLP-1 medications on bariatric surgery, the durability and safety of surgical treatment, and expanding access to obesity care. He also shares leadership lessons, the future of metabolic care, and why obesity should be treated as a disease rather than a character flaw.
The Future of Bariatric Surgery in the GLP-1 Era with Dr. C. Joe Northup
Next Up in Becker's Healthcare Podcast Episodes
-
In this episode, Fiona Fang, CEO of Aetna Better Health of Florida, discusses Medicaid challenges, maternal and infant health, whole…
-
In this episode, Dr. Lee Kojanis of Premier Oral & Maxillofacial Surgery in New Jersey joins the podcast to discuss…
-
In this episode, Terry McDonnell, DNP, RN, ACNP-BC, Senior Vice President and Chief Nurse Executive at Duke University Health System…
Comments are closed.